Correlation Between Akero Therapeutics and PDS Biotechnology
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and PDS Biotechnology Corp, you can compare the effects of market volatilities on Akero Therapeutics and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and PDS Biotechnology.
Diversification Opportunities for Akero Therapeutics and PDS Biotechnology
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Akero and PDS is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and PDS Biotechnology go up and down completely randomly.
Pair Corralation between Akero Therapeutics and PDS Biotechnology
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.77 times more return on investment than PDS Biotechnology. However, Akero Therapeutics is 1.29 times less risky than PDS Biotechnology. It trades about 0.07 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.04 per unit of risk. If you would invest 1,945 in Akero Therapeutics on September 4, 2024 and sell it today you would earn a total of 1,130 from holding Akero Therapeutics or generate 58.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. PDS Biotechnology Corp
Performance |
| Timeline |
| Akero Therapeutics |
| PDS Biotechnology Corp |
Akero Therapeutics and PDS Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and PDS Biotechnology
The main advantage of trading using opposite Akero Therapeutics and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |